D. E. Shaw & Co., Inc. - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,161,317
-80.4%
202,202
-55.2%
0.00%
-81.8%
Q2 2023$21,218,810
+12.8%
451,272
+0.7%
0.02%
+10.0%
Q1 2023$18,807,941
-19.1%
448,235
-26.5%
0.02%
-23.1%
Q4 2022$23,244,385
-17.7%
609,449
-15.5%
0.03%
-23.5%
Q3 2022$28,254,000
+12.0%
721,484
-7.6%
0.03%
+13.3%
Q2 2022$25,216,000
-19.5%
780,685
-17.5%
0.03%0.0%
Q1 2022$31,330,000
-25.9%
946,536
-4.8%
0.03%
-14.3%
Q4 2021$42,296,000
-24.0%
994,269
-20.9%
0.04%
-30.0%
Q3 2021$55,666,000
-30.1%
1,256,291
-10.4%
0.05%
-27.5%
Q2 2021$79,656,000
-43.1%
1,402,143
-25.1%
0.07%
-48.9%
Q1 2021$140,110,000
-26.2%
1,871,875
-14.7%
0.14%
-20.6%
Q4 2020$189,880,000
+26.1%
2,194,887
-10.9%
0.17%
+10.4%
Q3 2020$150,543,000
+66.3%
2,463,066
+13.1%
0.15%
+43.9%
Q2 2020$90,526,000
+662.8%
2,177,156
+426.9%
0.11%
+463.2%
Q1 2020$11,868,000
-8.1%
413,230
+130.9%
0.02%
+26.7%
Q4 2019$12,921,000
-55.3%
178,993
-13.1%
0.02%
-58.3%
Q3 2019$28,891,000
+54.2%
205,943
+101.3%
0.04%
+56.5%
Q2 2019$18,730,000
+15.1%
102,3000.0%0.02%
+9.5%
Q1 2019$16,271,000
+23.7%
102,300
-25.5%
0.02%
+16.7%
Q4 2018$13,152,000
-20.7%
137,300
+17.0%
0.02%
-5.3%
Q3 2018$16,575,000
-49.5%
117,346
-44.0%
0.02%
-54.8%
Q2 2018$32,825,000
+206.3%
209,709
+215.1%
0.04%
+200.0%
Q1 2018$10,718,000
-4.4%
66,543
-2.2%
0.01%
-12.5%
Q4 2017$11,207,000
+499.6%
68,043
+126.8%
0.02%
+433.3%
Q3 2017$1,869,000
-68.5%
30,000
-59.8%
0.00%
-70.0%
Q2 2017$5,941,000
+163.6%
74,597
+135.2%
0.01%
+150.0%
Q1 2017$2,254,000
+22.6%
31,715
-11.9%
0.00%
+33.3%
Q4 2016$1,838,000
+32.9%
36,000
+19.9%
0.00%0.0%
Q3 2016$1,383,000
+170.1%
30,025
+76.8%
0.00%
+200.0%
Q2 2016$512,000
+49.3%
16,978
+188.8%
0.00%0.0%
Q4 2015$343,0005,8780.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders